rs1060502649

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_004006.3(DMD):​c.7826G>A​(p.Gly2609Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000182 in 1,097,368 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 24)
Exomes 𝑓: 0.0000018 ( 0 hom. 1 hem. )

Consequence

DMD
NM_004006.3 missense

Scores

3
13

Clinical Significance

Uncertain significance criteria provided, single submitter U:2

Conservation

PhyloP100: 3.42

Publications

0 publications found
Variant links:
Genes affected
DMD (HGNC:2928): (dystrophin) This gene spans a genomic range of greater than 2 Mb and encodes a large protein containing an N-terminal actin-binding domain and multiple spectrin repeats. The encoded protein forms a component of the dystrophin-glycoprotein complex (DGC), which bridges the inner cytoskeleton and the extracellular matrix. Deletions, duplications, and point mutations at this gene locus may cause Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD), or cardiomyopathy. Alternative promoter usage and alternative splicing result in numerous distinct transcript variants and protein isoforms for this gene. [provided by RefSeq, Dec 2016]
DMD Gene-Disease associations (from GenCC):
  • Becker muscular dystrophy
    Inheritance: XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet
  • dilated cardiomyopathy 3B
    Inheritance: XL Classification: DEFINITIVE Submitted by: Ambry Genetics
  • Duchenne and Becker muscular dystrophy
    Inheritance: XL Classification: DEFINITIVE Submitted by: Myriad Women’s Health
  • Duchenne muscular dystrophy
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • progressive muscular dystrophy
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • symptomatic form of muscular dystrophy of Duchenne and Becker in female carriers
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.14190465).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DMDNM_004006.3 linkc.7826G>A p.Gly2609Asp missense_variant Exon 53 of 79 ENST00000357033.9 NP_003997.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DMDENST00000357033.9 linkc.7826G>A p.Gly2609Asp missense_variant Exon 53 of 79 1 NM_004006.3 ENSP00000354923.3

Frequencies

GnomAD3 genomes
Cov.:
24
GnomAD4 exome
AF:
0.00000182
AC:
2
AN:
1097368
Hom.:
0
Cov.:
30
AF XY:
0.00000276
AC XY:
1
AN XY:
362816
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26394
American (AMR)
AF:
0.00
AC:
0
AN:
35157
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19371
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30190
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54033
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40330
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4137
European-Non Finnish (NFE)
AF:
0.00000238
AC:
2
AN:
841699
Other (OTH)
AF:
0.00
AC:
0
AN:
46057
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
24

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Uncertain:1
Apr 06, 2017
Stanford Center for Inherited Cardiovascular Disease, Stanford University
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:provider interpretation

p.Gly2609Asp (c.7826G>A) in exon 53 of the DMD gene (NM_004006.2) Chromosome position X:31697538 C / T Given the lack of case data, and this variant's absence in the broader population, we classify it as being of unknown significance (VUS), concluding that there is not sufficient evidence for its pathogenicity to warrant using it for predictive genetic testing in family members. The DMD gene is associated with X-linked Duchenne Muscular Dystrophy (DMD) (MedGen UID:3925), Becker Muscular Dystrophy (BMD) (MedGen UID: 182959) and dilated cardiomyopathy (DCM) (MedGen UID: 472068). This is a completely novel variant. It has not been reported in the literature in association with disease, and it not present in population databases. Invitae reports that this variant is possibly mosaic in our patient, who has early-onset atrial fibrillation. It had not been reported to ClinVar (http://www.ncbi.nlm.nih.gov/clinvar/) by any lab as of 4/4/2017. This is a nonconservative amino acid change that replaces a nonpolar glycine with a negatively-charged aspartic acid. The glycine residue is not conserved across vertebrate species, and is frequently replaced with another nonpolar amino acid such as alanine or isoleucine. Of note, the default amino acid is aspartic acid in brush-tailed rat. No missense variants within 10 amino acids to either side are currently listed in ClinVar as Likely Pathogenic or Pathogenic. According to the Invitae report, algorithms developed to predict the effect of missense changes on protein structure and function (SIFT,PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies. This variant is not present in the gnomAD database, which includes variant calls on ~140,000 individuals of European, African, Latino, South Asian, Ashkenazi, and East Asian descent. There is good sequencing coverage at this site. The phenotype of those individuals is not publicly available. The dataset is comprised of multiple cohorts, some of which were recruited from the general population, others were enriched for common cardiovascular disease. The curators made an effort to exclude individuals with severe pediatric diseases. -

Duchenne muscular dystrophy Uncertain:1
Aug 29, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces glycine, which is neutral and non-polar, with aspartic acid, which is acidic and polar, at codon 2609 of the DMD protein (p.Gly2609Asp). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with DMD-related conditions. ClinVar contains an entry for this variant (Variation ID: 409927). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt DMD protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.093
BayesDel_addAF
Benign
-0.21
T
BayesDel_noAF
Benign
-0.54
CADD
Benign
18
DANN
Uncertain
0.98
DEOGEN2
Benign
0.22
.;T;T;.;.;T;.;.;T
FATHMM_MKL
Uncertain
0.80
D
LIST_S2
Uncertain
0.95
D;.;.;.;D;.;D;D;.
M_CAP
Benign
0.020
T
MetaRNN
Benign
0.14
T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-1.1
T
PhyloP100
3.4
PrimateAI
Benign
0.45
T
PROVEAN
Benign
-0.16
N;N;N;N;.;N;.;N;N
REVEL
Benign
0.13
Sift
Benign
0.16
T;T;T;T;.;D;.;T;T
Sift4G
Benign
0.075
T;T;T;T;D;D;D;D;T
Polyphen
0.21, 0.90, 0.25, 0.71
.;B;P;B;.;P;.;.;B
Vest4
0.17, 0.17, 0.17, 0.27, 0.20, 0.26, 0.20
MutPred
0.52
.;.;.;.;.;.;.;Loss of MoRF binding (P = 0.0573);.;
MVP
0.31
MPC
0.020
ClinPred
0.23
T
GERP RS
4.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
gMVP
0.56
Mutation Taster
=84/16
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1060502649; hg19: chrX-31697538; API